Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0001613,
umls-concept:C0007776,
umls-concept:C0011307,
umls-concept:C0013790,
umls-concept:C0022655,
umls-concept:C0030685,
umls-concept:C0034693,
umls-concept:C0034721,
umls-concept:C0220903,
umls-concept:C0391871,
umls-concept:C0547047,
umls-concept:C0599668,
umls-concept:C0599861,
umls-concept:C0680255,
umls-concept:C1283071,
umls-concept:C1519355,
umls-concept:C1948023,
umls-concept:C1963578
|
pubmed:issue |
3
|
pubmed:dateCreated |
1990-2-1
|
pubmed:abstractText |
The origin of cortical purine release was investigated by measuring [3H]purine release from electrically stimulated cortical slices of rats after neurotoxic lesions of cholinergic, noradrenergic and serotoninergic pathways innervating the cortex. Purines were labelled by incubating the cortical slices with [3H]adenine. The 3H efflux at rest and during stimulation, analysed by high performance liquid chromatography, consisted of adenosine, inosine, hypoxanthine and a small amount of nucleotides. Twenty days after unilateral or bilateral lesion of the nucleus basalis a marked decrease in choline acetyltransferase activity was associated with a decrease in [3H]purine release. A linear relationship was found between the decrease in choline acetyltransferase activity and [3H]purine release. A partial recovery in both choline acetyltransferase activity and [3H]purine release was observed eight months after the lesion. Twenty days after intra-cerebroventricular injection of 6-hydroxydopamine a 59% decrease in cortical noradrenaline content was associated with a 44% decrease in [3H]purine release. Conversely, no change in [3H]purine release was found in rats in which a 89% decrease in cortical serotonin content was induced by intra-cerebroventricular injection of 5,7-dihydroxytryptamine. The decrease in [3H]purine release after the lesion of the cholinergic and noradrenergic pathways may depend on metabolic changes, a loss of a stimulating influence of acetylcholine and noradrenaline or may indicate a release of [3H]purine from cholinergic and noradrenergic fibres.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adenosine,
http://linkedlifedata.com/resource/pubmed/chemical/Choline O-Acetyltransferase,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoxanthine,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoxanthines,
http://linkedlifedata.com/resource/pubmed/chemical/Ibotenic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Inosine,
http://linkedlifedata.com/resource/pubmed/chemical/Purines
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0306-4522
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
629-36
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2601836-Adenosine,
pubmed-meshheading:2601836-Adrenergic Fibers,
pubmed-meshheading:2601836-Animals,
pubmed-meshheading:2601836-Basal Ganglia,
pubmed-meshheading:2601836-Cerebral Cortex,
pubmed-meshheading:2601836-Choline O-Acetyltransferase,
pubmed-meshheading:2601836-Cholinergic Fibers,
pubmed-meshheading:2601836-Electric Stimulation,
pubmed-meshheading:2601836-Hypoxanthine,
pubmed-meshheading:2601836-Hypoxanthines,
pubmed-meshheading:2601836-Ibotenic Acid,
pubmed-meshheading:2601836-Inosine,
pubmed-meshheading:2601836-Male,
pubmed-meshheading:2601836-Nerve Degeneration,
pubmed-meshheading:2601836-Purines,
pubmed-meshheading:2601836-Rats,
pubmed-meshheading:2601836-Rats, Inbred Strains
|
pubmed:year |
1989
|
pubmed:articleTitle |
Cholinergic and noradrenergic denervations decrease labelled purine release from electrically stimulated rat cortical slices.
|
pubmed:affiliation |
Department of Preclinical, University of Florence, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|